Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lemborexant for Perioperative Sleep Quality in Breast Cancer Surgery
NCT07918300Phase 4Not yet recruiting
- Sponsor
- Beijing Tiantan Hospital
- Start
- Oct 2026
- Primary completion
- Jun 2027
01
Overview
Phase 4, randomised, double-blind trial in Postoperative sleep disturbance (PSD) comparing Lemborexant 5 mg with Placebo (2 arms). Primary endpoint: Richards-Campbell Sleep Questionnaire total score. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
lemborexant
03
Conditions
Postoperative sleep disturbance (PSD)
Beyond the preview
Go deeper on NCT07918300.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07918300.